View By Speaker
M. Agronin, MD
M. Alexander, PhD, MA
S. Ancoli-Israel, Ph.D
L. Boesky, PhD
R. Brown, PhD
A. Burstein, MD
R. Dougherty, PhD
J. Draud, MD, MS
P. Earley
G. Emslie, MD
L. Ereshefsky, PharmD
M. Forstein, MD
A. Frances, MD
M. Gold, MD
D. Goodman, MD
K. Gray, MD
D. Greenberg, MD
D. Greydanus, MD
R. Hendren, DO
R. Jackson, MD
R. Jain, MD, MPH
S. Jain, PsyD, LPC, MBA
J. Kane, MD
S. Katz, MSN PMH-CNS, BC
L. Kinsella, MD, FAAN
A. Krystal, MD
S. Levine, MD
J. Maldonado, MD
V. Maletic, MD, PA
B. McCarberg, MD
J. McGough, MD, MS
L. Miller, MD
L. Nagy, MD
H. Nasrallah, MD
S. Negi, MA, PhD
J. Nelson, MD
J. Newcomer, MD
G. Papakostas, MD
M. Piasecki, MD
J. Prince, MD
C. Raison, MD
P. Resnick, MD
A. Robb, MD
C. Rodgers, MD
M. Rosenberg, MD, PhD
J. Schim, MD
D. Schuyler, MD
S. Shea, MD
T. Simpatico, MD
T. Skale, MD
B. Smith, JD
T. Smith, MS Psych, PD, FASCP, LMHC, NCP
S. Sobel, MD
D. Sprague
M. Stein, MD, MPH
R. Stille, MBA
V. Strasburger, MD
J. Tsuang, MD
S. Verma, MD
J. Victoroff, MD, MA
J. Weiner, MD, PhD
S. Yaffe, MD
A. Young, MD, MSHS
|
Thursday, November 5| Thursday, November 5 07:45-09:00 a.m. |
411 - Advanced Topics in Psychiatric Malpractice PI 1.25 credits - Room: Mandalay Bay Ballroom AB |
Carla Rodgers, MD, Clinical Assistant Professor, University of Pennsylvania School of Medicine
|
Upon the completion of this activity, participants will be able to: - Define the legal basis of the concept of negligence;
- Enumerate the sources for the psychiatric standard of care; and
- Determine which types of health information are protected by HIPAA.
|
| Thursday, November 5 07:45-09:00 a.m. |
412 - Getting Home for Dinner: How To Be Efficient and Therapeutic with Time-demanding Patients and Families PT SC 1.25 credits - Room: Mandalay Bay Ballroom CD |
Joseph Weiner, MD, PhD, Chief, Division of Consultation-Liaison Psychiatry, North Shore University Hospital, Manhasset, N.Y.; Associated Professor of Clinical Psychiatry and Medicine, Albert Einstein College of Medicine
|
The practice of psychiatry can be a source of both great satisfaction and great stress. By participating in this activity, attendees will be able to: - Identify professional goals;
- Recognize the steps for recovering from burnout and avoiding burnout altogether; and
- Discuss the management of career-specific stressors, and how they can achieve balance between their personal and professional lives to maximize satisfaction.
|
| Thursday, November 5 07:45-09:00 a.m. |
413 - Dosage Formulation Technologies for Psychotropics: The Edge of the Pharmacokinetic-Pharmacodynamic Interface RX 1.25 credits - Room: Breakers EFKL |
Larry Ereshefsky, PharmD, Chief Scientific Officer, California Clinical Trials; VP, Principal Clinical Pharmacologist, and Psychiatric Therapeutic Expert, PAREXEL International; Clinical Professor, Psychiatry, University of Texas Health Science Center, San Antonio
|
Upon the completion of this activity, participants will be able to: - List Five Strategies to Modify Delivery of Medications;
- Explain what are the possible pharmacodynamic advantages, which result from dosage formulation related changes in drug concentrations at their sites of action;
- Identify future strategies for drug delivery and monitoring systems;
- Summarize data available supporting (or not) the advantages of novel dosage forms;
- Describe research strategies (and clinical approaches) to study the safety and efficacy of novel antipsychotic dosage forms.
|
| Thursday, November 5 07:45-09:00 a.m. |
414 - Autistic Spectrum Disorder: DOS vs. Windows CA PD 1.25 credits - Room: Mandalay Bay Ballroom IJ |
Doris Greenberg, MD, Associate Clinical Professor, Pediatrics; Mercer University School of Medicine; Developmental and Behavioral Pediatrician; Backus Children's Hospital at Memorial University Medical Center; Savannah, Georgia
|
This lecture will try to offer help in early detection, ways to conceptualize the disorder for families, and will emphasize the role of the practitioner to coordinate the many services and therapies needed. It will also emphasize how to talk about alternative therapies which may be questionable and how to treat comorbid symptoms. It should provide an approach to the patient who is early in diagnosis to help shape family attitudes toward constructive outcomes. By participating in this session, attendee will be able to - List why there is a need for early autism interventions.
- Recognize the necessity of initiating treatment immediately once a diagnosis of autism is suspected.
- Recognize the early and unique signs of the autistic spectrum disorder in order to begin intervention.
- Diagnose co-morbid problems which may respond to medication in autistic spectrum disorders.
- Evaluate the role of a physician in directing parents and patients through the complexities of services required.
|
| Thursday, November 5 09:15-10:30 a.m. |
421 - Professional Stress and Distress - How To Avoid Burnout and Even Thrive in Your Career! PI 1.25 credits - Room: Mandalay Bay Ballroom CD |
Joseph Weiner, MD, PhD, Chief, Division of Consultation-Liaison Psychiatry, North Shore University Hospital, Manhasset, N.Y.; Associated Professor of Clinical Psychiatry and Medicine, Albert Einstein College of Medicine
|
Dr. Weiner, a nationally regarded clinician and educator, has dedicated his career to helping health care professionals from medical students to chairmen of departments become happier people and better clinicians. This course, which will allow active audience participation, is based on years of working with stressed clinicians individually and in groups. At the end of this course, the audience will learn tools to successfully work on three things: - Identify the top causes of his or her professional stress.
- Map out a personal plan to diminish or eliminate these stresses.
- Create "SMART" goals and clear outcome measures to better align your career with what you value in life.
|
| Thursday, November 5 09:15-10:30 a.m. |
423 - Male Hypoactive Sexuality Disorder PT 1.25 credits - Room: Mandalay Bay Ballroom KL |
Stephen Levine, MD, Clinical Professor of Psychiatry, Case Western Reserve University; Co-Director of the Center for Marital and Sexual Health, Beachwood, Ohio
|
This lecture explores the phenomenon of limited male sexual interest and its relationship to the diagnosis of HSDD. It attempts to develop clinical sophistication and skepticism so that mental health professionals can efficiently decode patient presentations of low libido. Participants should be able to: - To understand the separate roles of drive, motivation, and internalized cultural values in shaping sexual desire.
- To realize that low sexual desire is quite clinically common in all psychiatric settings but HSDD is not.
- To approach male sexual dysfunction with sophistication-desire and arousal problems are not always distinct-and skepticism-men lie about their sexual lives.
|
| Thursday, November 5 09:15-10:30 a.m. |
424 - Personality Disorders PD 1.25 credits - Room: Lagoon EFKL |
Allen Frances, MD, Professor Emeritus, Department of Psychiatry, Duke University; Chair, DSM-IV Task Force and Expert Consensus Guidelines Project
|
Though we all have a personality, a disorder exists only when personality traits have become so extreme, inflexible, and maladaptive that they markedly impair functioning and get the person in the same kind of trouble over and over again. It's Differentiation from normalcy will be discussed along with classification and corresponding treatment techniques, including: psychodynamic, cognitive, behavioral, interpersonal, and supportive. Upon the completion of this activity, participants will be able to: - Describe the adaptive value of personality traits, how these survived via natural selection, and how to support them in helping patients cope with medical and psychiatric illness.
- Distinguish personality disorders from Axis I conditions.
- List several cognitive, behavioral, psychodynamic, supportive, and paradoxical approaches to the treatment personality disorders.
|
| Thursday, November 5 09:15-10:30 a.m. |
425 - The Delicate Art of Eliciting Suicidal Ideation and Other Sensitive Material, Part 1: Five Secrets for Uncovering Hidden and Taboo Material PD PT 1.25 credits - Room: Breakers ABGH |
Shawn Shea, MD, Director, Training Institute for Suicide Assessment and Clinical Interviewing, N.H.
|
Part 1 of this 2-part course is titled "Five Secrets for Uncovering Hidden and Taboo Material." This informative and insightful talk discusses innovative techniques for increasing validity while exploring sensitive material such as suicidal ideation. By participating in this activity, attendees will be able to: - Recognize the following five interviewing techniques for increasing validity: the behavioral incident, shame attenuation, gentle assumption, symptom amplification and denial of the specific;
- Discuss the theory behind the use of these five techniques for uncovering valid information when exploring sensitive areas such as domestic violence, substance abuse histories and antisocial behavior; and
- Describe and flexibly weave the above five validity techniques into effective methods of uncovering sensitive material while maintaining a powerful engagement.
|
| Thursday, November 5 09:15-10:30 a.m. |
426 - What Happened to Novel Development of Drugs To Treat Schizophrenia: Back to the Future? PD NP 1.25 credits - Room: Breakers EFKL |
Larry Ereshefsky, PharmD, Chief Scientific Officer, California Clinical Trials; VP, Principal Clinical Pharmacologist, and Psychiatric Therapeutic Expert, PAREXEL International; Clinical Professor, Psychiatry, University of Texas Health Science Center, San Antonio
|
Upon the compleion of this activiy, participants will be able to: - Describe the typical study design strategies used for the approval of a new antipsychotic in the United States and the European Union;
- List the newly approved (and not approved) medications for the treatment of schizophrenia, and how they differ from current therapies;
- Describe how the deconstruction of schizophrenia into endophenotypes and syndromes has stimulated a new generation of pharmacotherapeutic research and;
- List novel possible drug therapies that appear to work via glutamate/glycinergic.
|
| Thursday, November 5 09:15-10:30 a.m. |
427 - Club Drugs and Their Psychiatric Manifestations RX PD NP 1.25 credits - Room: Lagoon ABCGHI |
John Tsuang, MD, Clinical Professor, Psychiatry and Biobehavioral Science, Harbor-UCLA Medical Center
|
This talk explores the ongoing concerns about the increase in the popularity of a socially designated class of drugs known as "club drugs." By participating in this activity, attendees will be able to: - Discuss the major categorization of club drugs and their pharmacological properties;
- Identify the clinical and psychiatric manifestations of club drugs; and
- Recognize available treatment approaches and harm reduction and prevention strategies.
|
| Thursday, November 5 09:15-10:30 a.m. |
428 - Tourette's Syndrome: A Trinity of Symptoms CA RX PD 1.25 credits - Room: Mandalay Bay Ballroom IJ |
Doris Greenberg, MD, Associate Professor of Pediatrics, Mercer University School of Medicine, Savannah, GA
|
This Lecture will outline the current thinking about Tourette syndrome since it often includes co-morbid ADHD, OCD, and Anxiety Disorders. The make up of this trinity will be discussed and the ramification of making this diagnosis, as well as impart on insurability, and the natural cause of the disorder. Medication use for symptoms in the context of the comorbid problems will be discussed. By participating in this education activity, participants will be able to: - List the symptoms of Tourette's syndrome and differentiate the types of tics and movements which are often associated with this syndrome.
- Recognize the potentiality for co-morbid diagnoses like ADHD and OCD.
- Discuss the characteristics of a proper evaluation and also appreciate what not to do.
- List resources to help patients and families once a diagnosis is made.
- Understand the role of medications in treating the tics as well as the co-morbidities.
|
| Thursday, November 5 10:45-12:00 p.m. |
431 - How To Be an Expert Witness PI 1.25 credits - Room: Mandalay Bay Ballroom AB |
Carla Rodgers, MD, Clinical Assistant Professor, University of Pennsylvania School of Medicine
|
Upon the completion of this activity, participants will be able to: - Define the difference between forensic versus clinical evaluation.
- Demonstrate knowledge of the concept of agency.
- List the differences in approach between evaluating a clinical treatment patient and a forensic evaluee.
|
| Thursday, November 5 10:45-12:00 p.m. |
432 - The Delicate Art of Eliciting Suicidal Ideation and Other Sensitive Material: Part 2 PD PT 1.25 credits - Room: Breakers ABGH |
Shawn Shea, MD, Director, Training Institute for Suicide Assessment and Clinical Interviewing, N.H.
|
Part 2 of this 2-part course is titled "An Innovative Method for Eliciting Suicidal Ideation-the Chronological Assessment of Suicide Events." This informative and insightful talk discusses the practical application of the interview strategies for eliciting suicidal ideation and behavior in different psychiatric settings. By participating in this activity, attendees will be able to: - Recognize the role of 4 specific interviewing techniques for improving the validity of elicited suicidal ideation while decreasing errors of omission and optimizing engagement;
- Define the theory and practical application of a specific interview strategy for the elicitation of suicidal ideation and behaviors: the Chronological Assessment of Suicide Events (CASE approach); and
- Discuss and flexibly utilize the above approach as a sensitive and rapid method of uncovering suicidal ideation and intent in a busy clinic or hospital setting.
|
| Thursday, November 5 10:45-12:00 p.m. |
433 - Psychiatry: Past, Present, Future PI 1.25 credits - Room: Lagoon EFKL |
Allen Frances, MD, Professor Emeritus, Department of Psychiatry, Duke University; Chair, DSM-IV Task Force and Expert Consensus Guidelines Project
|
Over the ages, our patients have at times been revered as saints, murdered as witches, and harmed with all manner of treatments that amounted to physical Abuse and/or poisoning. From the advent of humane psychiatry in the nineteenth century brought, the development of scientific psychiatry in the twentieth century, there has so far been surprisingly little transfer between the remarkably rich findings of neuroscience and the day to day clinical practice of psychiatry. We will discuss likely future trends and why a deep understanding of obsessive/compulsive disorder and bipolar disorder will probably long precede an understanding of major depression or schizophrenia. - Upon the comletion of this activity, participants will be able to:
- Describe how present day psychiatry emerged from myth and folk medicine and what the legacy of the past suggests about our future.
- Discuss he remarkable advances in neuroscience in the past 50 years and how these have, and have not, influenced the clinical practice of psychiatry.
- List likely ways in which psychiatric diagnosis and treatment will evolve in the coming decades.
|
| Thursday, November 5 10:45-12:00 p.m. |
434 - Pharmacology of Dual Diagnosis Patients RX PD 1.25 credits - Room: Lagoon ABCGHI |
John Tsuang, MD, Clinical Professor, Psychiatry and Biobehavioral Science, Harbor-UCLA Medical Center
|
Upon the completion of this activity, participants will be able to: - Describe the relative risk of comorbid substance abuse with other psychiatric syndromes.
- Identify the available pharmacological agents for treatment of dual-diagnosis patients and medication treatment for substance dependence disorders.
- Discuss the difficulties relating to the treatment and the harm reduction model vs. the abstinence model for dual-diagnosis patients.
|
| Thursday, November 5 10:45-12:00 p.m. |
435 - Sexual Addictions PT PD 1.25 credits - Room: Mandalay Bay Ballroom KL |
Stephen Levine, MD, Clinical Professor of Psychiatry, Case Western Reserve University; Co-Director of the Center for Marital and Sexual Health, Beachwood, Ohio
|
Sexual excesses, particularly among men, have been known to exist since antiquity. The rise of the Internet and its exploding technologies have created frequent requests by wives and patients themselves for help with the loss of control over sexual behaviors. While not yet a DSM diagnostic category, the treatment of sexual addiction syndromes require a sophisticated clinical knowledge of sexual and general mental disorders. Upon the completion of this activity, participants will be able to: - To be able to interact with patients without countertransference moral revulsion.
- To be able to focus on the sexual excesses as the clinical problem rather than the associated psychopathology.
- To understand the allure of pornography for normal individuals and for those with sexual excesses.
|
| Thursday, November 5 10:45-12:00 p.m. |
437 - Motion in Emotion: Science and Art of Bringing Physical Exercise into your Treatment Plan PD CAM 1.25 credits - Room: Mandalay Bay Ballroom CD |
Rakesh Jain, MD, MPH, Director of Psychiatric Drug Research, R/D Clinical Research Center, Lake Jackson, Texas Charles Raison, MD, Associate Professor
Clinical Director Mind-Body Program
Department of Psychiatry and Behavioral Sciences
Emory University School of Medicine
Atlanta, GA
|
Does "Motion', that is, exercise have a place in our treatment armamentarium? This is a question all clinicians have frequently asked of themselves. The last decade of clinical and animal research has revealed surprising powerful positive effects of exercise on mood disorders. We now know that exercise affects brain volume, inflammatory cytokines, and the autonomic system. Clinical research data also points to exercise's powerful anti-depressant effects. In light of these exciting findings, this seminar is aimed at providing clinicians the research findings, as will as provide attendees with tools on how to "prescribe" exercise to their patients. Clinicians will be provided with tools to assist them in implementing an exercise prescribing program in their practices. Upon the completion of the this activity, participants will be able to: - Develop an scientifically and data based appreciation of the complex neurobiology of exercise's positive effects on on mood.
Examine the clinical, randomized data of exercise treatment in mood disorder and develop practical skills in applying this information to clinical care of patients.
|
|